Sridhar Kosaraju - May 16, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Sridhar Kosaraju
Stock symbol: TXG
Transactions as of: May 16, 2022
Transactions value $: $172,200
Form type: 4
Date filed: 5/17/2022, 05:30 PM
Previous filing: Apr 4, 2022
Next filing: May 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Options Exercise	$172K	+15K	+433.78%	$11.48^*	18.5K	May 16, 2022	Direct
holding	TXG	Class A Common Stock						3K	May 16, 2022	See footnote (1)	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-15K	-13.74%	$0.00	94.2K	May 16, 2022	Class A Common Stock	15K	$11.48	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.
F2	This option, originally for 130,000 shares, of which 35,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares.

Content

These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.

This option, originally for 130,000 shares, of which 35,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares.